Company Overview

SYNERGY PHARMACEUTICALS INC. (NASDAQ: SGYP)

Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.

We are committed to scientifically driven innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.

We have pioneered discovery, research and development efforts on analogs of uroguanylin, a naturally occurring human GI peptide, for the treatment of GI diseases and disorders.  We discovered, are developing and control 100% worldwide rights to our proprietary uroguanylin based GI platform that includes one commercial product, TRULANCE™ (plecanatide), and a second lead product candidate - dolcanatide.

On January 19, 2017, TRULANCE was approved in the United States for the treatment of adults with chronic idiopathic constipation (CIC) and is now available in U.S. pharmacies. The recommended dosage of TRULANCE is 3 mg taken orally, once daily, with or without food at any time of the day.

On March 24, 2017, we submitted a supplemental new drug application (sNDA) for TRULANCE for the treatment of adults with irritable bowel syndrome with constipation (IBS-C).

We are based in New York City, with research, technical operations and commercial offices in suburban Philadelphia. Synergy [SGYP] became a public company in July 2008 and is currently listed on NASDAQ.

Dolcanatide is our second uroguanylin analog currently being explored for ulcerative colitis.

We are based in New York City, with research, technical operations and commercial offices in suburban Philadelphia. Synergy [SGYP] became a public company in July 2008 and is currently listed on NASDAQ.

ContraVir Stock Distribution—Information Statement

Stock Information

SGYP

NASDAQ

Volume

Market Cap

Change

Day High

Day Low

Events

Upcoming Event

42nd Annual Deutsche Bank Healthcare Conference

May 3, 2017 • 12:50PM EDT

Archived Event

Oppenheimer 27th Annual Healthcare Conference

Mar 21, 2017 • 11:30AM EDT

Webcast

Archived Event

Leerink Partners 6th Annual Global Healthcare Conference

Feb 15, 2017 • 11:00AM EDT

Webcast

View All Events